Sale

Drug Screening Market

Global Drug Screening Market Size, Trends, Growth, Analysis, Forecast: By Product and Services: Drug Screening Services, Drug Screening Products, Rapid Testing Devices (RTD), Oral Fluid Testing Devices, Consumables; By End User: Workplace and Schools, Others; Regional Analysis; Supplier Landscape; 2024-2032

Global Drug Screening Market Outlook

The global drug screening market value was USD 7.97 billion in 2023, driven by the increasing prevalence of drug abuse across the globe. The market size is anticipated to grow at a CAGR of 13.8% during the forecast period of 2024-2032 to achieve a value of USD 25.50 billion by 2032.

 

drug screening market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America to be a Significant Regional Market for Drug Screening

North America is anticipated to be the largest regional market for drug screening. The dominance of the North American market can be ascribed to factors such as rising illicit drug usage, government funding available to combat drug abuse, regulations supporting drug screening, the rising incidence of accidents caused by alcohol impairment, and the presence of key players in the region. Also, various initiatives are being implemented by the United States government to monitor the symptoms and determine whether a person is under drug abuse. For example, the Patients and Communities Act of 2018 was enacted by the government of the United States to combat drug usage. As a result, increased drug and alcohol addiction and strict rules to detect intoxication in the body are likely to aid the market growth in the region over the forecast period. The increasing cases of accidents caused by drunk driving is another major factor expected to contribute to revenue growth in countries such as the United States over the forecast period.

 

Urine Samples Segment to Hold the Largest Market Share

Based on the sample type, the urine samples segment revenue is expected to expand at a rapid rate in the drug screening market throughout the forecast period as drug presence can be easily detected and is painless compared to a blood sample. Urine is the most commonly utilised for testing drug abuse, and it is a simple sample to analyse. The benefits it offers, such as cost-effectiveness, the high detection accuracy of multiple drugs and instant results, are further driving the growth of the market. Urine drug testing is a critical aspect of monitoring patients on long-term opioid therapy and has also been recommended for patients on a long-term benzodiazepine or stimulant therapy. Also, it is one of the crucial tests to check opioid dependency. Thus, the rising prevalence of opioid overdose is expected to drive market growth over the forecast period.

 

Market Segmentations

Drug screening is a technique for detecting illegal and prescription drugs in blood, urine, and other bodily fluids. Potential medications are found and optimised using this process before a candidate drug is chosen for clinical trials. In high-throughput screening tests, huge libraries of compounds are screened for a specific biological activity.

 

drug screening market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on products and services, the market includes:

  • Drug Screening Product
    • Analytical Instruments
    • Rapid Testing Devices
    • Oral Fluid Testing Devices
    • Consumables
  • Drug Screening Service

By sample type, the market is divided into:

  • Urine Samples
  • Breath Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other

The end-users of the market are:

  • Drug Testing Laboratories
  • Workplaces
  • Criminal Justice and Law Enforcement Agencies
  • Hospitals
  • Drug Treatment Centres
  • Individual Users
  • Pain Management Centres
  • Schools and Colleges

The regional markets for the drug screening market can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

 

drug screening market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Growing Consumption of Drug and Alcohol Augmenting the Market Growth

The growth in the global drug screening market can be attributed to the growing drug and alcohol consumption, increasing road accidents due to overdose of drugs while driving, rising regulatory approvals for drug screening products and services, illegal alcohol use by teens, and prescription drug misuse. The development of advanced screening devices and growing awareness regarding the benefits of alcohol or drug screening in the workplace creates new opportunities for key players in the market. For example, advanced drug-testing processes can be used in the workplace to identify illicit narcotics in sweat molecules and saliva using fingerprint tests and mouth swabs. The "lab-on-a-chip" technology can identify amphetamines, MDMA, cocaine, and opiates, among other drugs.

In addition, rising government measures to counter drug misuse, an increase in clinical studies, and the enforcement of strict laws and regulations demanding alcohol and drug testing in public safety services are likely to boost the drug screening market’s growth over the forecast period. Furthermore, the screening is easy to implement, thus offering flexible and effective workplace drug testing, which is also expected to fuel market growth.

 

Key Players in the Global Drug Screening Market

The report gives a detailed analysis of the following key players in the global drug screening market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Laboratory Corporation of America® Holdings.
  • Quest Diagnostics
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Alfa Scientific Designs Inc.
  • OraSure Technologies, Inc.
  • F. Hoffmann-La Roche Ltd
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product and Services
  • End User
  • Region
Breakup by Products and Services
  • Drug Screening Services
  • Drug Screening Products
  • Rapid Testing Devices (RTD)
  • Oral Fluid Testing Devices
  • Consumables
Breakup by End User
  • Workplace and Schools
  • Criminal Justice Systems and Law Enforcement Agencies
  • Drug Testing Laboratories
  • Drug Treatment Centers
  • Hospitals
  • Personal Users
  • Pain Management Centers
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • LabCorp
  • Quest Diagnostics
  • Abbott
  • Thermo Fisher Scientific, Inc.
  • Alfa Scientific Designs, Inc.
  • OraSure Technologies, Inc.
  • Siemens
  • F. Hoffmann-La Roche Ltd
  • MPD Inc.
  • Shimadzu Corporation
  • Lifeloc Technologies, Inc.
  • Drägerwerk AG & Co. KGaA
  • Premier Biotech, Inc.
  • Omega Laboratories, Inc.
  • Psychemedics Corporation
  • Clinical Reference Laboratory Inc.,
  • American Bio Medica Corporation
  • ACM Global Laboratories
  • Sciteck, Inc.
  • Synens SAS
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Drug Screening Market Overview 

    3.1    Global Drug Screening Market Historical Value (2017-2023) 
    3.2    Global Drug Screening Market Forecast Value (2024-2032)
4    Global Drug Screening Market Landscape
    4.1    Global Drug Screening Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Drug Screening Product Landscape
        4.2.1    Analysis by Product Type
        4.2.2    Analysis by End User
        4.2.3    Analysis by Region
5    Global Drug Screening Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Drug Screening Market Segmentation
    6.1    Global Drug Screening Market, by Product and Services
        6.1.1    Market Overview 
        6.1.2    Drug Screening Services
        6.1.3    Drug Screening Products
            6.1.3.1    Analytical Instruments
                6.1.3.1.1    Breathalyzers
                    6.1.3.1.1.1    Law Enforcement Agencies Breathalyzers
                    6.1.3.1.1.2    Fuel Cell Breathalyzers
                    6.1.3.1.1.3    Semi-Conductor Breathalyzers
                    6.1.3.1.1.4    Others
            6.1.3.2    Immunoassay Analyzers
            6.1.3.3    Chromatography Instruments
        6.1.4    Rapid Testing Devices (RTD)
            6.1.4.1    Urine Testing Devices
            6.1.4.2    Drug Testing Cups
            6.1.4.3    Dip Cards
            6.1.4.4    Drug Testing Cassettes
        6.1.5    Oral Fluid Testing Devices
        6.1.6    Consumables
            6.1.6.1    Assay Kits
            6.1.6.2    Sample Collection Devices
            6.1.6.3    Calibrators & Controllers
            6.1.6.4    Others 
    6.2    Global Drug Screening Market, by End User
        6.2.1    Market Overview
        6.2.2    Workplace and Schools
        6.2.3    Criminal Justice Systems and Law Enforcement Agencies
        6.2.4    Drug Testing Laboratories
        6.2.5    Drug Treatment Centers
        6.2.6    Hospitals
        6.2.7    Personal Users
        6.2.8    Pain Management Centers
        6.2.9    Others
    6.3    Global Drug Screening Market by Region
        6.3.1    Market Overview
        6.3.2    North America 
        6.3.3    Europe
        6.3.4    Asia Pacific
        6.3.5    Latin America
        6.3.6    Middle East and Africa
7    North America Drug Screening Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Drug Screening Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Drug Screening Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Drug Screening Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Drug Screening Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
    16.2    US FDA
    16.3    EU EMA
    16.4    INDIA CDSCO
    16.5    JAPAN PMDA
    16.6    Others
17    Supplier Landscape
    17.1    LabCorp
        17.1.1    Financial Analysis
        17.1.2     Product Portfolio
        17.1.3     Demographic Reach and Achievements
        17.1.4     Mergers and Acquisitions
        17.1.5     Certifications
    17.2    Quest Diagnostics
        17.2.1    Financial Analysis
        17.2.2     Product Portfolio
        17.2.3     Demographic Reach and Achievements
        17.2.4     Mergers and Acquisitions
        17.2.5     Certifications
    17.3    Abbott
        17.3.1    Financial Analysis
        17.3.2     Product Portfolio
        17.3.3     Demographic Reach and Achievements
        17.3.4     Mergers and Acquisitions
        17.3.5     Certifications
    17.4    Thermo Fisher Scientific, Inc.
        17.4.1    Financial Analysis
        17.4.2     Product Portfolio
        17.4.3     Demographic Reach and Achievements
        17.4.4     Mergers and Acquisitions
        17.4.5     Certifications
    17.5    Alfa Scientific Designs, Inc.
        17.5.1    Financial Analysis
        17.5.2     Product Portfolio
        17.5.3     Demographic Reach and Achievements
        17.5.4     Mergers and Acquisitions
        17.5.5     Certifications
    17.6    OraSure Technologies, Inc.
        17.6.1    Financial Analysis
        17.6.2     Product Portfolio
        17.6.3     Demographic Reach and Achievements
        17.6.4     Mergers and Acquisitions
        17.6.5     Certifications
    17.7    Siemens
        17.7.1    Financial Analysis
        17.7.2     Product Portfolio
        17.7.3     Demographic Reach and Achievements
        17.7.4     Mergers and Acquisitions
        17.7.5     Certifications
    17.8    F. Hoffmann-La Roche Ltd
        17.8.1    Financial Analysis
        17.8.2     Product Portfolio
        17.8.3     Demographic Reach and Achievements
        17.8.4     Mergers and Acquisitions
        17.8.5     Certifications
    17.9    MPD Inc.
        17.9.1    Financial Analysis
        17.9.2     Product Portfolio
        17.9.3     Demographic Reach and Achievements
        17.9.4     Mergers and Acquisitions
        17.9.5     Certifications
    17.10    Shimadzu Corporation
        17.10.1    Financial Analysis
        17.10.2     Product Portfolio
        17.10.3     Demographic Reach and Achievements
        17.10.4     Mergers and Acquisitions
        17.10.5     Certifications
    17.11    Lifeloc Technologies, Inc.
        17.11.1    Financial Analysis
        17.11.2     Product Portfolio
        17.11.3     Demographic Reach and Achievements
        17.11.4     Mergers and Acquisitions
        17.11.5     Certifications
    17.12    Drägerwerk AG & Co. KGaA
        17.12.1    Financial Analysis
        17.12.2     Product Portfolio
        17.12.3     Demographic Reach and Achievements
        17.12.4     Mergers and Acquisitions
        17.12.5     Certifications
    17.13    Premier Biotech, Inc.
        17.13.1    Financial Analysis
        17.13.2     Product Portfolio
        17.13.3     Demographic Reach and Achievements
        17.13.4     Mergers and Acquisitions
        17.13.5     Certifications
    17.14    Omega Laboratories, Inc.
        17.14.1    Financial Analysis
        17.14.2     Product Portfolio
        17.14.3     Demographic Reach and Achievements
        17.14.4     Mergers and Acquisitions
        17.14.5     Certifications
    17.15    Psychemedics Corporation
        17.15.1    Financial Analysis
        17.15.2     Product Portfolio
        17.15.3     Demographic Reach and Achievements
        17.15.4     Mergers and Acquisitions
        17.15.5     Certifications
    17.16    Clinical Reference Laboratory Inc.,
        17.16.1    Financial Analysis
        17.16.2     Product Portfolio
        17.16.3     Demographic Reach and Achievements
        17.16.4     Mergers and Acquisitions
        17.16.5     Certifications
    17.17    American Bio Medica Corporation
        17.17.1    Financial Analysis
        17.17.2     Product Portfolio
        17.17.3     Demographic Reach and Achievements
        17.17.4     Mergers and Acquisitions
        17.17.5     Certifications
    17.18    ACM Global Laboratories 
        17.18.1    Financial Analysis
        17.18.2     Product Portfolio
        17.18.3     Demographic Reach and Achievements
        17.18.4     Mergers and Acquisitions
        17.18.5     Certifications
    17.19    Sciteck, Inc.
        17.19.1    Financial Analysis
        17.19.2     Product Portfolio
        17.19.3     Demographic Reach and Achievements
        17.19.4     Mergers and Acquisitions
        17.19.5     Certifications
    17.20    Synens SAS
        17.20.1    Financial Analysis
        17.20.2     Product Portfolio
        17.20.3     Demographic Reach and Achievements
        17.20.4     Mergers and Acquisitions
        17.20.5     Certifications
18    Global Drug Screening Market- Distribution Model (Additional Insight)
    18.1    Overview
    18.2    Potential Distributors
    18.3    Key Parameters for Distribution Partner Assessment
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Pricing Models and Strategies (Additional Insight)
    21.1    Overview
    21.2    Cost Model
        21.2.1    Manufacturing Cost Analysis
        21.2.2    Procurement Cost Analysis
        21.2.3    Clinical Trial Cost Factors
    21.3    Pricing Strategies
        21.3.1     Competitor Pricing Analysis
        21.3.2     Key Assessment of Product Attributes
        21.3.3     Pricing Benchmark

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

Drug screening was valued at USD 7.97 billion in 2023.

The market is expected to grow at a CAGR of 13.8% from 2024 to 2032 to reach USD a value of USD 25.50 billion by 2032.

The major drivers of the market include the rising prevalence of opioid overdose, increasing road accidents due to overdose of drugs while driving, rising regulatory approvals for drug screening products and services, illegal alcohol use by teens, prescription drug misuse, development of advanced screening devices, growing awareness regarding the benefits of alcohol or drug screening in the workplace, and increase in clinical studies.

The growing drug and alcohol consumption and rising government measures to counter drug misuse are the key industry trends propelling the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Based on products and services, the market is divided into drug screening product and drug screening service. Drug screening product is further divided into analytical instruments, rapid testing devices, oral fluid testing devices, and consumables.

Based on sample type, the market is divided into urine samples, breath samples, oral fluid samples, and hair samples, among others.

The end-users of the market include drug testing laboratories, workplaces, criminal justice and law enforcement agencies, hospitals, drug treatment centres, individual users, pain management centres, schools and colleges.

The major players in the market include Laboratory Corporation of America® Holdings., Quest Diagnostics, Abbott Laboratories, Thermo Fisher Scientific Inc., Alfa Scientific Designs Inc., OraSure Technologies, Inc., and F. Hoffmann-La Roche Ltd, among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER